14th European Congress of Clinical Microbiology and Infectious ...

Scientific Programme Sunday, May 2, 2004
Meet-the-Expert Sessions
Small Should we treat asymptomatic bacteriuria?
Hall Experts: Raul Raz (Afula, IL)
E20 Francisco Soriano (Madrid, E)
07:15
Objectives:
The clinical significance and management of
asymptomatic bacteriuria (ASB) in different
groups of patients will be discussed:
pregnant women, children aged 5-6 years,
patients undergoing genitourinary procedures
or with indwelling catheters, patients with
intermittent catheterization, elderly and
diabetic patients, healthy school girls and
young women.
Club A Interpretative reading of antibiotic
E21 susceptibility tests
07:15 Experts: Luis Martinez-Martinez (Santander, E)
Ian Phillips (Malaga, E)
Objectives:
Interactive session for discussion of actual
cases in which interpretative reading of the
antibiogram of both Gram-positive and
Gram-negative pathogens has a major clinical
impact on reporting susceptibility testing data.
Meeting Sexually transmitted infections, HIV and
Hall IV travel: prevention and disease management
E22 Experts: Philip Tarr (Lausanne, CH)
07:15 George Schmid (Geneva, CH)
Objectives:
Update and discussion of the prevention of
STIs, vaccines for the HIV infected traveler,
diarrhea, antiretroviral therapy during travel,
geographic specific disease prevention,
management of common questions and
problems upon return.
Meeting Diagnosis of anaerobes in the microbiology
Hall V lab: costs and benefits?
E23 Experts: Jon Brazier (Cardiff, UK)
07:15 Arne Rodloff (Leipzig, D)
Objectives:
This session will critically assess the
indications and methods for the diagnosis
of anaerobes , with special considerations to
the cost in relation to the potential clinical
benefits.
Chamber Infection control
Hall Experts: Geoffrey Scott (London, UK)
E24 Niels Frimodt-Møller (Copenhagen, DK)
07:15
Objectives:
To discuss the crucial issues of how to control
nosocomial spread of infections. By examining
case studies, to consider how important
hospital-acquired infections actually are
(or could be) in the age of MRSA and GRE
and how to control them.
Conference
How to manage multi-drug resistant
Hall Pseudomonas aeruginosa infections
E25 Experts: Ian Gould (Aberdeen, UK);
07:15 Jordi Vila (Barcelona, E)
Auditorium
Objectives:
To discuss how P. aeruginosa acquire
multiresistance, what are the risk factors
for acquisition, what is the role of biofilm
production in resistance and what is best
empirical treatment based on the above
mentioned knowledge.
ESCMID Award of Excellence
Campylobacter, from obscurity to celebrity
Chairperson: Marc Struelens (Brussels, B)
President of ESCMID
26
08:30 Jean Paul Butzler (Brussels, B)
Webcast
�
ESCMID Excellence Awardee 2004
Please see page 15 for further information on the
ESCMID Award of Excellence 2004
www.escmid.org/eccmid2004 page 31